EXCLUSIVE: LBI Entertainment has signed for management the prolific Emmy winning writer, director and producer Danny Strong.

BioBond Continues to Grow Its IP Portfolio to Commercialize Sustainable Adhesives and Coating Solutions LAFAYETTE, INDIANA / ...

A bipartisan coalition of states, including Tennessee, will receive $7.4 billion from Purdue Pharma, Inc. and members of the Sackler family for their “instrumental” role in the crisis.

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

Potentially $57 million, according to a proposed settlement agreement with the family that once owned Purdue Pharma and has been sued by several states to account for its role in the opioid crisis.

Bankrupt Purdue Pharma and its owners have agreed to pay $7.4 billion (€7.1 billion) to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...

In a multi-billion dollar settlement, New York State stands to receive up to $250 million from Purdue Pharma and the family at the helm of the company, the Sacklers. Purdue Pharma is behind the ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the prescription ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

The yearslong bankruptcy case could be coming to a close. Purdue Pharma’s owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid ...